Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants

计划入组 24 人 · 首次发布于 2016 年 6 月 7 日

Trial of Two Strains of BCG

计划入组 12,006 人 · 首次发布于 2015 年 5 月 19 日

Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

计划入组 40 人 · 首次发布于 2016 年 11 月 2 日

Bacillus calmette-guerin substrain russian BCG-I live antigen(VERITY-BCG)

Bacille Calmette-Guerin vaccine (S. Andrea Hospital)

Bacillus Calmette-Guerin(ImmunityBio)

JUNG JUNG CAMILLE

France

Nutrin GmbH

Germany

PALMETTO RETINA CENTER, LLC

United States

Novel TB Vaccines and AI-Driven Solutions Show Promise in Global Fight Against Tuberculosis

Indonesia Launches Phase 3 Trial of M72 Tuberculosis Vaccine Amid Safety Assurances

CDC Awards $1.6 Million Grant for Controversial Hepatitis B Vaccine Study in Guinea-Bissau